Showing results (81-90 of 339) with videos related to

Sort By:
Pageof 34
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 27, 2004
Histological findings of a surgically excised myopic choroidal neovascular membrane after photodynamic therapy. A case reportA Scupola, L Ventura, A C Tiberti, et al.
Pharmacology & Therapeutics|April 24, 2025
USP1 inhibition: A journey from target discovery to clinical translationCarlos Torrado, Nicholas W Ashton, Alan D D'Andrea, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
DUB-1, a deubiquitinating enzyme with growth-suppressing activityY Zhu, M Carroll, F R Papa, et al.
The Journal of Clinical Investigation|October 6, 2010
Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cellsPatrizia Vinciguerra, Susana A Godinho, Kalindi Parmar, et al.
Experimental Hematology|December 26, 2001
Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cellsM A Siddique, K Nakanishi, T Taniguchi, et al.
Molecular and Cellular Biology|September 19, 1998
Functional activity of the fanconi anemia protein FAA requires FAC binding and nuclear localizationD Näf, G M Kupfer, A Suliman, et al.
Acta Ophthalmologica Scandinavica. Supplement|February 11, 1999
The role of class I and class II HLA antigens in primary open angle glaucoma (POAG)G Ferreri, A D'Andrea, I Castagna, et al.
The Journal of Biological Chemistry|November 4, 2006
Structural determinants of human FANCF protein that function in the assembly of a DNA damage signaling complexPrzemyslaw Kowal, Allan M Gurtan, Patricia Stuckert, et al.
Molecular and Cellular Biology|April 1, 1994
A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformationD L Barber, J C DeMartino, M O Showers, et al.
Cancer Discovery|June 21, 2017
DNA Damage and Repair Biomarkers of Immunotherapy ResponseKent W Mouw, Michael S Goldberg, Panagiotis A Konstantinopoulos, et al.
Pageof 34